活性分子抑制剂-Amadis Chemical

图片	名称及描述
	5,21-二氧代-25-((3aS,4S,6aR)-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-基)-10,13,16-三氧杂-6,20-二氮杂二十五烷酸 Biotinyl-NH-PEG3-C3-amido-C3-COOH A10102111202761-21-4 97%	Detail
	维森库单抗 Vesencumab A10102271205533-60-3 97%	Detail
	曲利组单抗 Tregalizumab A10102481207446-68-1 97%	Detail
	Tepilamide fumarate \| XP-23829 \| Others Tepilamide fumarate A10102591208229-58-6 97%	Detail
	Utreloxastat Utreloxastat A10102871213269-96-5 97%	Detail
	6-(4-(氨基甲基)-2-氯苯氧基)苯并[c][1,2]氧硼杂环戊烷-1(3H)-醇 AN-3485 A10102951213827-99-6 97%	Detail
	(E)-(2-甲氧基-5-(3-氧代-3-(3,4,5-三甲氧基苯基)丙-1-烯-1-基)苯基)硼酸 YK-3-237 A10103111215281-19-8 97%	Detail
	Vincristine-d Vincristine-d A10103861217854-24-4 97%	Detail
	3-(2-((2-氯-4-氟-5-(3-甲基-2,6-二氧代-4-(三氟甲基)-3,6-二氢嘧啶-1(2H)-基)苯基)硫基)丙酰胺基)丙酸甲酯 Tiafenacil A10104581220411-29-9 97%	Detail
	(S)-2-(4-氨基苯基)-7-甲氧基-8-(3-(((S)-7-甲氧基-2-(4-甲氧基苯基)-5-氧代-5,11a-二氢-1H-苯并[e]吡咯并[1,2-a][1,4]二氮杂卓-8-基)氧基)丙氧基)-1,11a-二氢-5H-苯并[e]吡咯并[1,2-a][1,4]二氮杂卓-5-酮 SGD-1882 A10104771222490-34-7 97%	Detail
	佐利米定 Zolimidine A10104811222-57-7 97%	Detail
	WZ4141 WZ4141 A10104841222776-76-2 97%	Detail
	(S,E)-4-(二甲氨基)-N-(3-(4-((2-羟基-1-苯乙基)氨基)-6-苯基呋喃并[2,3-d]嘧啶-5-基)苯基)丁-2-烯酰胺 DBPR112 A10105191226549-49-0 98%	Detail
	1-(4-氨基-2-丁基-1H-咪唑并[4,5-c]喹啉-1-基)-2-甲基丙-2-醇 TLR7 agonist 3 A10105851229024-78-5 97%	Detail
	TEPRASIRAN Teprasiran A10106071231737-88-4 97%	Detail
	Valecobulin hydrochloride Valecobulin hydrochloride A10106571240321-53-2 97%	Detail
	2,5-二氧代吡咯烷-1-基 5-((4-(1,2,4,5-四嗪-3-基)苄基)氨基)-5-氧代戊酸酯 Tetrazine-Ph-NHCO-C3-NHS ester A10106751244040-64-9 97%	Detail
	1-[4-[2-(4-甲基苯基)-1,2-二苯基乙烯基]苯基]-1H-吡咯-2,5-二酮 TPE-MI A10106871245606-71-6 97%	Detail
	Zuclopenthixol-d Zuclopenthixol-d A10107361246833-97-5 97%	Detail
	1,1'-(1,3-亚苯基双(亚甲基))双(1-环庚基-3-(4-(二甲基氨基)苯基)脲) YM17E A1010743124900-72-7 97%	Detail